Peru vs Zambia: The number of people with susceptibility test result for rifampicin
Peru
13,453
in 2021
Zambia
16,922
in 2021
Peru rank
18th
Zambia rank
17th
The number of people with susceptibility test result for rifampicin over time
- Peru
- Zambia
How they compare
Zambia currently reports 16,922 against 13,453 in Peru, a difference of 3,469.
That makes Zambia's figure about 1.3 times Peru's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Peru ahead.
Peru ranks 18th and Zambia ranks 17th of 155 countries.
Across the 2 decades both report, Peru averaged higher in 1 and Zambia in 1.
Head to head by decade
| Decade | Peru | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13,485 | 10,301 | 3,184 | Peru |
| 2020s | 11,518 | 16,156 | 4,638 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Peru or Zambia?
- Zambia, at 16,922 against 13,453 in Peru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Peru and Zambia?
- 3,469, with Zambia ahead.
- How many years of comparable data are there for Peru and Zambia?
- 5 years are reported by both, from 2017 to 2021.
- How do Peru and Zambia rank globally for the number of people with susceptibility test result for rifampicin?
- Peru ranks 18th and Zambia ranks 17th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.